The relative efficacies of tobramycin and ciprofloxacin against pseudomonas aeruginosa in vitro and in normal and granulocytopenic mice
Tóm tắt
Ciprofloxacin was studiedin vitro and in an experimental thigh infection model in mice to evaluate its efficacy againstPseudomonas aeruginosa in comparison with that of tobramycin. Thein vivo experiments were carried out in normal mice as well as mice rendered granulocytopenic by irradiation. The MIC of ciprofloxacin for two Pseudomonas strains was 0.125 mg/l and 0.25 mg/l and that of tobramycin 0.25 mg/l and 4.0 mg/l, respectively.In vitro short-term growth experiments revealed that as far as initial killing rate is concerned, ciprofloxacin was 2.20 times as potent as tobramycin against the first strain and 45.4 times as potent against the second strain. Thein vivo experiments were performed by injecting the micro-organism into the thigh muscle and counting colony forming units (CFUs) after several hours of exposure to the antibiotics. The results for irradiated mice indicate that ciprofloxacin was 2.0 times as potent as tobramycin against the first strain and 37.8 times as potent against the second strain, when related to dosage. For normal mice these values were 2.0 and 16.0, respectively, which is more than would be expected from thein vitro experiments because the mean plasma concentrations of tobramycin were about four times higher than those of ciprofloxacin.
Tài liệu tham khảo
King, A., Shannon, K., Phillips, I. Thein vitro activity of ciprofloxacin and nalidixic acid. J. Antimicrob. Chemother. 13 (1984) 325–331.
Reeves, D. S., Bywater, M. J., Holt, H. A., White, L. O. In vitro studies with ciprofloxacin, a new 4-quinolone compound. J. Antimicrob. Chemother. 13 (1984) 333–346.
Wise, R., Andrews, J. M., Edwards, L. J. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents. Antimicrob. Agents Chemother. 23 (1983) 559–564.
Gordin, F. M., Hackbarth, C. J., Scott, K. G., Sande, M. A. Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs. Antimicrob. Agents Chemother. 27 (1985) 452–454.
Kemmerich, B., Small, G. J., Pennington, J. E.: Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimentalPseudomonas aeruginosa pneumonia. Antimicrob. Agents Chemother. (1986) 395–399.
Bouquet Jimenez, E., Dalet Escriba, F., Caballe, L. In vitro activity of the newer quinolones compared with the classic ones and tobramycin. Infection 13 (1985) 41–44.
Rowland, M., Tozer, T. N. Clinical pharmacokinetics, concepts and applications. Lea and Febiger, Philadelphia 1980.
Mattie, H. A mathematical description of short term effects of beta lactam antibiotics on bacterial growthin vitro. Curr. Microbiol. 1 (1978) 105–109.
Mattie, H., van der Voet, G. B. The relative potency of amoxicillin and ampicillinin vitro andin vivo. Scand. J. Infect. Dis. 13 (1981) 291–296.
Armitage, P. Statistical methods in medical research. Blackwell Scientific Publications, Oxford, London, Melbourne 1971.
van der Voet, G. B., Mattie, H., van Furth, R. Quantitative determination of the effect of granulocytes on the course of experimental infections during antibiotic treatment. Infection 12 (1984) 5–9.